GW Pharmaceuticals Ret. on assets
What is the Ret. on assets of GW Pharmaceuticals?
The Ret. on assets of GW Pharmaceuticals is -7.64%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with ret. on assets similar to GW Pharmaceuticals
- Savannah Resources Plc has Ret. on assets of -7.66%
- TransAtlantic Petroleum has Ret. on assets of -7.65%
- Syncom Healthcare has Ret. on assets of -7.65%
- Linus Digital Finance Ag has Ret. on assets of -7.65%
- BlackRock MuniYield Michigan Quality Fund Inc has Ret. on assets of -7.65%
- Science in Sport plc has Ret. on assets of -7.64%
- GW Pharmaceuticals has Ret. on assets of -7.64%
- Longtable has Ret. on assets of -7.64%
- Damstra Hldgs Ltd has Ret. on assets of -7.64%
- Damstra Ltd has Ret. on assets of -7.64%
- Asia-express Logistics has Ret. on assets of -7.64%
- Fantasia Co has Ret. on assets of -7.63%
- Elemental Royalties Ltd has Ret. on assets of -7.63%